📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force. (2016)

First Author: Strehl C

Attributed to: Advancing therapeutics by exploiting single cell functional analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2015-208916

PubMed Identifier: 26933146

Publication URI: http://europepmc.org/abstract/MED/26933146

Type: Journal Article/Review

Volume: 75

Parent Publication: Annals of the rheumatic diseases

Issue: 6

ISSN: 0003-4967